{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:45Z","timestamp":1786995705226,"version":"build-2736575974"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFD1601004"],"award-info":[{"award-number":["2021YFD1601004"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1600403"],"award-info":[{"award-number":["2023YFD1600403"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1600402"],"award-info":[{"award-number":["2023YFD1600402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2024 ZC-YYDP-110"],"award-info":[{"award-number":["2024 ZC-YYDP-110"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["ZYJXG-Y23005"],"award-info":[{"award-number":["ZYJXG-Y23005"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013147","name":"Research Program of Science and Technology at Universities of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2022YFSH0001"],"award-info":[{"award-number":["2022YFSH0001"]}],"id":[{"id":"10.13039\/501100013147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013147","name":"Research Program of Science and Technology at Universities of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["DJK-2023\\u2013004"],"award-info":[{"award-number":["DJK-2023\\u2013004"]}],"id":[{"id":"10.13039\/501100013147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024CY-JJQ-36"],"award-info":[{"award-number":["2024CY-JJQ-36"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2022JM-451"],"award-info":[{"award-number":["2022JM-451"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474054"],"award-info":[{"award-number":["82474054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Province","doi-asserted-by":"publisher","award":["23JP034"],"award-info":[{"award-number":["23JP034"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.phrs.2025.107898","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:57:47Z","timestamp":1754434667000},"page":"107898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["From molecular chaos to precision medicine in the treatment of cardiac hypertrophy: A rational use of natural products by integrating artificial intelligence and multi-omics data"],"prefix":"10.1016","volume":"219","author":[{"given":"Jinhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanxian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5261-6101","authenticated-orcid":false,"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2025.107898_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ejhf.1632","article-title":"Concentric vs. Eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment","volume":"22","author":"Nauta","year":"2020","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2025.107898_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107898_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"13","key":"10.1016\/j.phrs.2025.107898_bib4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.phrs.2025.107898_bib5","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2025.107898_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcvm.2019.00020","article-title":"Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure","volume":"6","author":"Gogiraju","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","article-title":"Mechanisms for the transition from physiological to pathological cardiac hypertrophy","volume":"98","author":"Oldfield","year":"2020","journal-title":"Can. J. Physiol. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2025.107898_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009417","article-title":"Regression of left ventricular mass in athletes undergoing complete detraining is mediated by decrease in intracellular but not extracellular compartments","volume":"12","author":"Swoboda","year":"2019","journal-title":"Circ. Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib10","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1152\/ajpendo.00158.2021","article-title":"Insulin signaling in the heart","volume":"321","author":"Abel","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib11","first-page":"0","article-title":"New insights into IGF-1 signaling in the heart","volume":"39","author":"Lee","year":"2024","journal-title":"Physiol. (Bethesda)"},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020397","article-title":"The mTOR signaling pathway: key regulator and therapeutic target for heart disease","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2025.107898_bib13","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00748.2024","article-title":"Cardiac remodeling in heart disease and the importance of thyroid hormones","author":"Gerdes","year":"2025","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-024-01756-w","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases","volume":"9","author":"Qian","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"21-22","key":"10.1016\/j.phrs.2025.107898_bib16","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1080\/15384101.2023.2293595","article-title":"Transforming growth factor-\u03b2 and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy","volume":"22","author":"Wen","year":"2023","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phrs.2025.107898_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cbi.2019.04.024","article-title":"Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT\/ GSK-3\u03b2 signaling pathway","volume":"307","author":"Shang","year":"2019","journal-title":"Chem. Biol. Inter."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10060931","article-title":"Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure","volume":"10","author":"Shah","year":"2021","journal-title":"Antioxidants"},{"issue":"16","key":"10.1016\/j.phrs.2025.107898_bib19","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.114.013895","article-title":"Inhibition of hypertrophy, per se, May not be a good therapeutic strategy in ventricular pressure overload: other approaches could be more beneficial","volume":"131","author":"Crozatier","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2025.107898_bib21","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31083\/j.rcm2305165","article-title":"Cardiac hypertrophy: from pathophysiological mechanisms to heart failure development","volume":"23","author":"Caturano","year":"2022","journal-title":"Rev. Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102411","article-title":"Unraveling the complex pathophysiology of heart failure: insights into the role of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)","volume":"49","author":"Maryam","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2013.02.047","article-title":"Phospholipase C\u03b5 hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010569","article-title":"Aerobic exercise attenuates pressure Overload-Induced myocardial remodeling and myocardial inflammation via upregulating miR-574-3p in mice","volume":"17","author":"Chen","year":"2024","journal-title":"Circ. Heart Fail"},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/ATVBAHA.123.319601","article-title":"p53 acetylation exerts critical roles in pressure Overload-Induced coronary microvascular dysfunction and heart failure in mice","volume":"44","author":"He","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2025.107898_bib27","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2021.12","article-title":"Role of metabolomics in identifying cardiac hypertrophy: an overview of the past 20 years of development and future perspective","volume":"23","author":"Singh","year":"2021","journal-title":"Expert Rev. Mol. Med"},{"issue":"10","key":"10.1016\/j.phrs.2025.107898_bib28","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1021\/acs.jproteome.4c00142","article-title":"Characteristics of myocardial structure and central carbon metabolism during the early and compensatory stages of cardiac hypertrophy","volume":"23","author":"Chen","year":"2024","journal-title":"J. Proteome Res"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib29","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.athoracsur.2017.04.046","article-title":"Histone modification is correlated with reverse left ventricular remodeling in nonischemic dilated cardiomyopathy","volume":"104","author":"Ito","year":"2017","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.phrs.2025.107898_bib30","article-title":"Innate immune cells in pressure Overload-Induced cardiac hypertrophy and remodeling","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/jcmm.14129","article-title":"Molecular biomarkers in cardiac hypertrophy","volume":"23","author":"Zhu","year":"2019","journal-title":"J. Cell Mol. Med"},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jacc.2017.12.008","article-title":"A surprising noncanonical role for calcineurin in Pressure-Induced cardiac hypertrophy","volume":"71","author":"Shaw","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.phrs.2025.107898_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612625","article-title":"Spatial transcriptomic analysis of focal and normal areas of myocyte disarray in human hypertrophic cardiomyopathy","volume":"24","author":"Laird","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib34","article-title":"Single-cell spatial transcriptomics in cardiovascular development, disease, and Medicine","volume":"11","author":"Han","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.phrs.2025.107898_bib35","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.csbj.2023.04.007","article-title":"Single-cell and spatial transcriptomics: advances in heart development and disease applications","volume":"21","author":"Long","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.phrs.2025.107898_bib36","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.csbj.2023.04.007","article-title":"Single-cell and spatial transcriptomics: advances in heart development and disease applications","volume":"21","author":"Long","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacbts.2024.09.004","article-title":"Targeting the Gut-Heart axis improves cardiac remodeling in a clinical scale model of cardiometabolic syndrome","volume":"10","author":"Herisson","year":"2025","journal-title":"JACC Basic Translational Science"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052242","article-title":"Role of gut microbial metabolites in ischemic and Non-Ischemic heart failure","volume":"26","author":"Hatamnejad","year":"2025","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin h facilitates cardiomyopathy via Slc7a11-Mediated ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2025.107898_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175676","article-title":"Ginsenoside Rb1 promotes the activation of PPAR\u03b1 pathway via inhibiting FADD to ameliorate heart failure","volume":"947","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"7838","key":"10.1016\/j.phrs.2025.107898_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.phrs.2025.107898_bib42","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-023-01378-8","article-title":"Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122251","article-title":"Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7150\/ijbs.17617","article-title":"PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT\/mTOR pathway","volume":"13","author":"Zhao","year":"2017","journal-title":"Int J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2025.107898_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","article-title":"DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics","volume":"145","author":"Zhuang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2025.107898_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171323","article-title":"Oxytocin attenuates cardiac hypertrophy by improving cardiac glucose metabolism and regulating OXTR\/JAK2\/STAT3 axis","volume":"182","author":"Yang","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2025.107898_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113134","article-title":"Interleukin (IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2\/STAT3-signaling associated inflammation and oxidative stress","volume":"142","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/jcp.25945","article-title":"HSF1 phosphorylation by ERK\/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy","volume":"233","author":"Huang","year":"2018","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib51","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"issue":"19","key":"10.1016\/j.phrs.2025.107898_bib52","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/emboj\/cdg474","article-title":"J.D. Molkentin, c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling","volume":"22","author":"Liang","year":"2003","journal-title":"Embo J."},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41419-022-04881-y","article-title":"GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK\/p38 signaling pathway","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bbrc.2020.03.188","article-title":"Distinct roles of calmodulin and Ca(2+)\/calmodulin-dependent protein kinase II in isopreterenol-induced cardiac hypertrophy","volume":"526","author":"Wang","year":"2020","journal-title":"Biochem Biophys. Res Commun."},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000371454","article-title":"Hyperphosphate-Induced myocardial hypertrophy through the GATA-4\/NFAT-3 signaling pathway is attenuated by ERK inhibitor treatment","volume":"5","author":"Liu","year":"2015","journal-title":"Cardiorenal Med"},{"issue":"10","key":"10.1016\/j.phrs.2025.107898_bib56","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/CIRCRESAHA.109.206581","article-title":"TRPC1 channels are critical for hypertrophic signaling in the heart","volume":"105","author":"Seth","year":"2009","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2025.107898_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2016.06.007","article-title":"CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift","volume":"98","author":"Uchinoumi","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib58","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11596-021-2426-y","article-title":"Decorin induces cardiac hypertrophy by regulating the CaMKII\/MEF-2 signaling pathway in vivo","volume":"41","author":"Yang","year":"2021","journal-title":"Curr. Med Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib59","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1002\/jcp.29242","article-title":"The combined inhibition of the CaMKII\u03b4 and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"23","key":"10.1016\/j.phrs.2025.107898_bib60","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00018-018-2885-x","article-title":"Crosstalk between FGF23- and angiotensin II-mediated ca (2+) signaling in pathological cardiac hypertrophy","volume":"75","author":"Mhatre","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.phrs.2025.107898_bib61","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13912","article-title":"Effects of hypoestrogenism and\/or hyperaldosteronism on myocardial remodeling in female mice","volume":"6","author":"Rouet-Benzineb","year":"2018","journal-title":"Physiol. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12012-019-09550-9","article-title":"Oleic acid protects from Arsenic-Induced cardiac hypertrophy via AMPK\/FoxO\/NFATc3 pathway","volume":"20","author":"Samanta","year":"2020","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.phrs.2025.107898_bib63","article-title":"AMP-Activated protein kinase signalling in cancer and cardiac hypertrophy","author":"Lipovka","year":"2015","journal-title":"Cardiovasc Pharm. Open Access 4(3"},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11427-017-9197-5","article-title":"AMPK and cardiac remodelling","volume":"61","author":"Feng","year":"2018","journal-title":"Sci. China Life Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib65","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/cbin.11566","article-title":"GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis","volume":"45","author":"Liao","year":"2021","journal-title":"Cell Biol. Int"},{"issue":"9","key":"10.1016\/j.phrs.2025.107898_bib66","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/abbs\/gmab099","article-title":"Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII\/AT1R\/ACE2 and AMPK\/mTOR\/p70S6K pathways","volume":"53","author":"Wang","year":"2021","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.phrs.2025.107898_bib67","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","article-title":"Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway","volume":"121","author":"Li","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2025.107898_bib68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2014.06.023","article-title":"AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1","volume":"558","author":"Li","year":"2014","journal-title":"Arch. Biochem Biophys."},{"issue":"11","key":"10.1016\/j.phrs.2025.107898_bib69","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200661","article-title":"Sophoricoside ameliorates cardiac hypertrophy by activating AMPK\/mTORC1-mediated autophagy","volume":"40","author":"Gao","year":"2020","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.phrs.2025.107898_bib70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41401-020-0401-y","article-title":"Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPAR\u03b1\/PGC-1 pathway","volume":"42","author":"Hou","year":"2021","journal-title":"Acta Pharm. Sin."},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib72","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/cr.2011.132","article-title":"Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice","volume":"22","author":"Wang","year":"2012","journal-title":"Cell Res"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib73","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.athoracsur.2017.04.060","article-title":"Mitochondrial dysfunction in atrial tissue of patients developing postoperative atrial fibrillation","volume":"104","author":"Jeganathan","year":"2017","journal-title":"Ann. Thorac. Surg."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib74","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1161\/01.RES.0000141774.29937.e3","article-title":"Nuclear receptor signaling and cardiac energetics","volume":"95","author":"Huss","year":"2004","journal-title":"Circ. Res"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib75","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.trsl.2015.06.003","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated t cells c4 signaling pathway","volume":"166","author":"Liu","year":"2015","journal-title":"Transl. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.celrep.2015.06.006","article-title":"Suppression of PGC-1\u03b1 is critical for reprogramming oxidative metabolism in renal cell carcinoma","volume":"12","author":"LaGory","year":"2015","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib77","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s10517-018-4082-1","article-title":"Pathological remodeling of the myocardium in chronic heart failure: role of PGC-1\u03b1","volume":"164","author":"Kulikova","year":"2018","journal-title":"Bull. Exp. Biol. Med"},{"key":"10.1016\/j.phrs.2025.107898_bib78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","article-title":"Toll-Like receptor 4 inhibition improves oxidative stress and mitochondrial health in Isoproterenol-Induced cardiac hypertrophy in rats","volume":"8","author":"Katare","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2025.107898_bib79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.intimp.2017.12.019","article-title":"Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4\/NF-\u03baB signaling pathway in mice","volume":"55","author":"Ma","year":"2018","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-016-0599-5","article-title":"MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to ang II and activating TLR4\/NF-\u03baB signaling pathway","volume":"112","author":"Han","year":"2017","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.phrs.2025.107898_bib81","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejphar.2017.11.031","article-title":"RETRACTED: LncRNA myocardial infarction-associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR-93","volume":"818","author":"Li","year":"2018","journal-title":"Eur. J. Pharm."},{"issue":"49","key":"10.1016\/j.phrs.2025.107898_bib82","doi-asserted-by":"crossref","first-page":"86784","DOI":"10.18632\/oncotarget.21424","article-title":"Indonesian herbal Medicine prevents hypertension-induced left ventricular hypertrophy by diminishing NADPH oxidase-dependent oxidative stress","volume":"8","author":"Sulistyowati","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107898_bib83","doi-asserted-by":"crossref","first-page":"1874985","DOI":"10.1155\/2018\/1874985","article-title":"N-Acetylcysteine reduces ROS-Mediated oxidative DNA damage and PI3K\/Akt pathway activation induced by helicobacter pylori infection","author":"Xie","year":"2018","journal-title":"Oxid. Med Cell Longev. 2018"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib84","doi-asserted-by":"crossref","first-page":"H980","DOI":"10.1152\/ajpheart.00768.2016","article-title":"Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism","volume":"312","author":"Guo","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib85","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.bbadis.2019.01.020","article-title":"Nrf2 deficiency aggravates angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6\/STAT3-dependent inflammation","volume":"1865","author":"Chen","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12265-020-10083-8","article-title":"NRF2 in cardiovascular diseases: a ray of hope!","volume":"14","author":"Vashi","year":"2021","journal-title":"J. Cardiovasc Transl. Res"},{"issue":"11","key":"10.1016\/j.phrs.2025.107898_bib87","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.7150\/ijbs.43825","article-title":"Cilostazol alleviate nicotine induced cardiomyocytes hypertrophy through modulation of autophagy by CTSB\/ROS\/p38MAPK\/JNK feedback loop","volume":"16","author":"Wang","year":"2020","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2025.107898_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115705","article-title":"Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway","volume":"300","author":"Chen","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107898_bib89","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1111\/bph.15333","article-title":"Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling","volume":"179","author":"R\u00fcdebusch","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.613123","article-title":"Effects of Cardiomyocyte-Specific deletion of STAT3-A murine model of heart failure with preserved ejection fraction","volume":"7","author":"Zhao","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","article-title":"Sacubitril\/Valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2025.107898_bib92","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","article-title":"Histone deacetylases in cardiovascular and metabolic diseases","volume":"130","author":"Bagchi","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103878","article-title":"Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy","volume":"29","author":"Wu","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2025.107898_bib94","doi-asserted-by":"crossref","first-page":"41337","DOI":"10.1038\/srep41337","article-title":"Melatonin ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1\u03b1-SIRT3 signaling","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib95","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41366-018-0030-4","article-title":"ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1\u03b1 deacetylation","volume":"42","author":"Wang","year":"2018","journal-title":"Int J. Obes. (Lond. )"},{"key":"10.1016\/j.phrs.2025.107898_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176071","article-title":"SOX4 as a potential therapeutic target for pathological cardiac hypertrophy","volume":"958","author":"Bin","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107573","article-title":"YAP K236 acetylation facilitates its nucleic export and deprived the protection against cardiac hypertrophy in mice","volume":"211","author":"Wang","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.phrs.2025.107898_bib98","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cellsig.2016.05.011","article-title":"Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ","volume":"28","author":"Lin","year":"2016","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib99","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI61084","article-title":"HDAC4 controls histone methylation in response to elevated cardiac load","volume":"123","author":"Hohl","year":"2013","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.phrs.2025.107898_bib100","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1111\/jcmm.14684","article-title":"Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2\/PGE2 pathway via a HDAC5\/HDAC6-dependent mechanism","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib101","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cvr\/cvu254","article-title":"miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8","volume":"105","author":"Yan","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2025.107898_bib102","doi-asserted-by":"crossref","first-page":"6227330","DOI":"10.1155\/2022\/6227330","article-title":"Hdac8 inhibitor alleviates transverse aortic Constriction-Induced heart failure in mice by downregulating Ace1","author":"Zhao","year":"2022","journal-title":"Oxid. Med Cell Longev. 2022"},{"issue":"10","key":"10.1016\/j.phrs.2025.107898_bib103","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.bbadis.2018.07.035","article-title":"A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy","volume":"1864","author":"Jiang","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"51","key":"10.1016\/j.phrs.2025.107898_bib104","doi-asserted-by":"crossref","first-page":"30596","DOI":"10.1074\/jbc.M115.673202","article-title":"Structure-based discovery of novel small molecule wnt signaling inhibitors by targeting the Cysteine-rich domain of frizzled","volume":"290","author":"Lee","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2025.107898_bib105","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/1535370219851243","article-title":"The cytoprotective impact of yes-associated protein 1 after ischemia-reperfusion injury in AC16 human cardiomyocytes","volume":"244","author":"Khan","year":"2019","journal-title":"Exp. Biol. Med."},{"issue":"22","key":"10.1016\/j.phrs.2025.107898_bib106","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1111\/febs.14969","article-title":"Diminished inhibition and facilitated activation of RyR2-mediated Ca(2+) release is a common defect of arrhythmogenic calmodulin mutations","volume":"286","author":"S\u00f8ndergaard","year":"2019","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.phrs.2025.107898_bib107","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.molmed.2022.06.007","article-title":"Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment","volume":"28","author":"Ajoolabady","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"13","key":"10.1016\/j.phrs.2025.107898_bib108","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-Dependent mitochondrial autophagy plays a protective role against pressure Overload-Induced mitochondrial dysfunction and heart failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib109","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCRESAHA.117.312317","article-title":"AMPK\u03b12 protects against the development of heart failure by enhancing mitophagy via PINK1 phosphorylation","volume":"122","author":"Wang","year":"2018","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2025.107898_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103563","article-title":"PDE4D inhibition ameliorates cardiac hypertrophy and heart failure by activating mitophagy","volume":"81","author":"Fu","year":"2025","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib111","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.yjmcc.2011.09.013","article-title":"Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice","volume":"51","author":"Kawashima","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib112","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171438","article-title":"Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1\u03b2","volume":"38","author":"Bai","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2025.107898_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2020.151653","article-title":"miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKK\u03b5","volume":"123","author":"Zhu","year":"2021","journal-title":"Acta Histochem"},{"key":"10.1016\/j.phrs.2025.107898_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-981-15-0602-4_3","article-title":"Regulation of autophagy by mTOR signaling pathway","volume":"1206","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.phrs.2025.107898_bib115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","article-title":"Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway","volume":"121","author":"Li","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107898_bib116","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10557-021-07220-z","article-title":"SLC7A11\/xCT prevents cardiac hypertrophy by inhibiting ferroptosis","volume":"36","author":"Zhang","year":"2022","journal-title":"Cardiovasc Drugs Ther."},{"issue":"6","key":"10.1016\/j.phrs.2025.107898_bib117","first-page":"1324","article-title":"Real-World artificial Intelligence-Based electrocardiographic analysis to diagnose hypertrophic cardiomyopathy","volume":"11","author":"Desai","year":"2025","journal-title":"JACC Clin. Electro"},{"issue":"5","key":"10.1016\/j.phrs.2025.107898_bib118","article-title":"Combining WGCNA and machine learning to identify mechanisms and biomarkers of ischemic heart failure development after acute myocardial infarction","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2025.107898_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104739","article-title":"A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling","volume":"155","author":"Gao","year":"2020","journal-title":"Pharm. Res"},{"issue":"10","key":"10.1016\/j.phrs.2025.107898_bib120","first-page":"1804","article-title":"Use of artificial intelligence including multimodal systems to improve the management of cardiovascular disease","volume":"40","author":"Jaltotage","year":"2024","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib121","doi-asserted-by":"crossref","DOI":"10.1111\/iep.12526","article-title":"KLF9 aggravates the cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy through the lncRNA UCA1\/p27 axis","volume":"106","author":"Ding","year":"2025","journal-title":"Int J. Exp. Pathol."},{"key":"10.1016\/j.phrs.2025.107898_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177346","article-title":"Therapeutic inhibition of PHF21B attenuates pathological cardiac hypertrophy by inhibiting the BMP4\/GSK3\u03b2\/\u03b2-catenin axis","volume":"991","author":"Sheng","year":"2025","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155250","article-title":"Astragaloside IV mitigates hypoxia-induced cardiac hypertrophy through calpain-1-mediated mTOR activation","volume":"125","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.107898_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176876","article-title":"Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: a target-based network pharmacology approach","volume":"981","author":"Cheng","year":"2024","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107841","article-title":"Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1\/NF-\u03baB pathway","volume":"98","author":"Ren","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107898_bib126","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1080\/21655979.2022.2031388","article-title":"Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.phrs.2025.107898_bib127","article-title":"Quercetin attenuates cardiac hypertrophy by inhibiting mitochondrial dysfunction through SIRT3\/PARP-1 pathway","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117624","article-title":"Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt\/\u03b2-catenin signaling pathway","volume":"252","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2025.107898_bib129","article-title":"Innovations in heart failure management: the role of cutting-edge biomarkers and multi-omics integration","volume":"11","author":"Bastos","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103005","article-title":"The future of cardiology: integrating single-cell transcriptomics with multi-omics for enhanced cardiac disease insights","volume":"50","author":"Tang","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.phrs.2025.107898_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143759","article-title":"A dual-peptides and specific promoter-modified nano gene delivery system for myocardial hypertrophy treatment","volume":"311","author":"Xing","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2025.107898_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.132979","article-title":"Artificial intelligence for left ventricular hypertrophy detection and differentiation on echocardiography, cardiac magnetic resonance and cardiac computed tomography: a systematic review","volume":"422","author":"Cirillo","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2025.107898_bib133","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gene.2019.02.056","article-title":"Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy","volume":"698","author":"Recamonde-Mendoza","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2025.107898_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177416","article-title":"Inhibition of ULK1 attenuates ferroptosis-mediated cardiac hypertrophy via HMGA2\/METTL14\/SLC7A11 axis in mice","volume":"995","author":"Zhang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107898_bib135","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.59942","article-title":"Inhibition of cholesteryl ester transfer protein contributes to the protection of ginsenoside re against Isoproterenol-Induced cardiac hypertrophy","author":"Qiu","year":"2024","journal-title":"Cureus 16(5"},{"key":"10.1016\/j.phrs.2025.107898_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154747","article-title":"C. Craig wan, baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway","volume":"114","author":"Cai","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.107898_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111509","article-title":"The synergistic protective effects of paeoniflorin and \u03b2-ecdysterone against cardiac hypertrophy through suppressing oxidative stress and ferroptosis","volume":"125","author":"Yan","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.phrs.2025.107898_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115106","article-title":"Urb. Attenuates cardiac hypertrophy and improves heart function through multi-level mechanisms revealed by systems pharmacology","volume":"291","author":"Ding","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2025.107898_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174975","article-title":"Valencene post-treatment exhibits cardioprotection via inhibiting cardiac hypertrophy, oxidative stress, nuclear factor- \u03baB inflammatory pathway, and myocardial infarct size in isoproterenol-induced myocardial infarcted rats; a molecular study","volume":"927","author":"Shervin Prince","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150343","article-title":"Carnosol suppresses cardiomyocyte hypertrophy via promoting the activation of AMPK pathway","volume":"729","author":"Tian","year":"2024","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.phrs.2025.107898_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103437","article-title":"Antrodia cinnamomea triterpenoids attenuate cardiac hypertrophy via the SNW1\/RXR\/ALDH2 axis","volume":"78","author":"Ma","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2025.107898_bib142","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jare.2024.02.008","article-title":"Valerenic acid attenuates pathological myocardial hypertrophy by promoting the utilization of multiple substrates in the mitochondrial energy metabolism","volume":"68","author":"Liu","year":"2025","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.phrs.2025.107898_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105823","article-title":"Combination of 1,8-cineole and beta-caryophyllene synergistically reverses cardiac hypertrophy in isoprenaline-induced mice and H9c2 cells","volume":"124","author":"Bai","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phrs.2025.107898_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.870699","article-title":"Liquiritin attenuates pathological cardiac hypertrophy by activating the PKA\/LKB1\/AMPK pathway","volume":"13","author":"Aiyasiding","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155970","article-title":"Cardamonin intervenes in myocardial hypertrophy progression by regulating Usp18","volume":"134","author":"Feng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2025.107898_bib146","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.freeradbiomed.2024.01.007","article-title":"Breviscapine protects against pathological cardiac hypertrophy by targeting FOXO3a-mitofusin-1 mediated mitochondrial fusion","volume":"212","author":"Lin","year":"2024","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phrs.2025.107898_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115618","article-title":"Cyclovirobuxine d alleviates aldosterone-induced myocardial hypertrophy by protecting mitochondrial function depending on the mutual regulation of Nrf2-SIRT3","volume":"167","author":"Wang","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115275","article-title":"Resveratrol prevents ang II-induced cardiac hypertrophy by inhibition of NF-\u03baB signaling","volume":"165","author":"Ma","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176081","article-title":"Lutein suppresses ferroptosis of cardiac microvascular endothelial cells via positive regulation of IRF in cardiac hypertrophy","volume":"959","author":"Liu","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154543","article-title":"Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway","volume":"109","author":"Sun","year":"2023","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phrs.2025.107898_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29040760","article-title":"Chlorogenic acid attenuates isoproterenol Hydrochloride-Induced cardiac hypertrophy in AC16 cells by inhibiting the Wnt\/\u03b2-Catenin signaling pathway","volume":"29","author":"He","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2025.107898_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115168","article-title":"Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N(6)-methyladenosine RNA modification in cardiomyocytes","volume":"165","author":"Cui","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107898_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174687","article-title":"Trans-cinnamaldehyde suppresses microtubule detyrosination and alleviates cardiac hypertrophy","volume":"914","author":"Tian","year":"2022","journal-title":"Eur. J. Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:49:45Z","timestamp":1772880585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":153,"alternative-id":["S1043661825003238"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107898","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From molecular chaos to precision medicine in the treatment of cardiac hypertrophy: A rational use of natural products by integrating artificial intelligence and multi-omics data","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107898"}}